产品说明
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Valsartan Related Compound B was used as working standard during validation of HPLC method for quantifying valsartan and hydrochlorthiazide combination from tablet formulation.
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
USP issued SDS can be found here.
Sales restrictions may apply.
基本信息
| 经验(实验)分子式 | C23H27N5O3 |
| 分子量 | 421.49 |
| MDL编号 | MFCD19689078 |
| PubChem化学物质编号 | 329751481 |
| NACRES | NA.24 |
产品性质
| 等级 | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| application(s) | pharmaceutical (small molecule) |
| 格式 | neat |
| SMILES string | CCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(O)=O |
| InChI | 1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1 |
| InChI key | OKAQHVJSXLGXET-NRFANRHFSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Warning |
| 危险声明 | H336 - H361d |
| 预防措施声明 | P202 - P261 - P271 - P280 - P304 + P340 + P312 - P308 + P313 |
| 危险分类 | Repr. 2 - STOT SE 3 |
| 靶器官 | Central nervous system |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
